Northwest Investment Counselors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$125K Buy
+1,487
New +$113K 0.03% 176
2024
Q2
Sell
-1,313
Closed -$96.2K 281
2024
Q1
$96.2K Buy
+1,313
New +$101K 0.02% 184
2023
Q4
Sell
-1,313
Closed -$98.4K 282
2023
Q3
$98.4K Hold
1,313
0.03% 181
2023
Q2
$101K Buy
1,313
+82
+7% +$6.54K 0.03% 181
2023
Q1
$102K Hold
1,231
0.03% 186
2022
Q4
$106K Hold
1,231
0.03% 185
2022
Q3
$76K Hold
1,231
0.02% 181
2022
Q2
$76K Hold
1,231
0.02% 178
2022
Q1
$73K Buy
1,231
+68
+6% +$4.35K 0.02% 192
2021
Q4
$84K Buy
+1,163
New +$80.1K 0.02% 188
2021
Q2
Sell
-1,051
Closed -$68K 256
2021
Q1
$68K Buy
+1,051
New +$67.8K 0.02% 196
2020
Q4
Sell
-1,168
Closed -$74K 253
2020
Q3
$74K Buy
+1,168
New +$81K 0.03% 162
2019
Q4
Sell
-1,051
Closed -$67K 286
2019
Q3
$67K Buy
+1,051
New +$68.7K 0.02% 199
2017
Q4
Sell
-814
Closed -$66K 200
2017
Q3
$66K Hold
814
0.03% 159
2017
Q2
$58K Buy
+814
New +$54.2K 0.03% 162

Other funds holding GILD

Northwest Investment Counselors's GILD Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Gilead Sciences (GILD) in Q3 2024: 1,487 shares worth $125K. The stake represents 0.03% of the portfolio and ranks #176 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in GILD as recently as Q1 2024.

Northwest Investment Counselors first reported a position in GILD in Q2 2017 and has held it in 15 quarters since. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Northwest Investment Counselors held 1,487 shares of Gilead Sciences worth $125K as of Q3 2024.
  • Gilead Sciences was a new Northwest Investment Counselors position in Q3 2024.
  • Gilead Sciences made up 0.03% of Northwest Investment Counselors's portfolio in Q3 2024, its #176 holding.
  • Northwest Investment Counselors first reported a position in Gilead Sciences in Q2 2017 and has held it in 15 quarters since.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.